Fig. 4: Representative chest CT images.
From: Efficacy and tolerability of bevacizumab in patients with severe Covid-19
Typical chest CT images of a Chinese patient with severe Covid-19 who received bevacizumab at day 8 (b) relative to the prior treatment baseline (a). Typical chest CT images of an Italian patient with severe Covid-19 who received bevacizumab at day 7 (d) relative to the prior treatment baseline (c).
